search
Back to results

Personalized or Precision Medicine in the Dietary Approach to Obesity (PI21/01677)

Primary Purpose

Obesity

Status
Not yet recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
MedDiet Arm
KetoDiet Arm
IF Arm
Sponsored by
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Obesity focused on measuring Precision medicine, nutrigenomics, microbiome, obesity, diet

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • Participants aged ≥ 18 and <70 years old who were derived to the obesity-management unit of the Endocrinology and Nutrition Unit of the Virgen de la Victoria Hospital (Málaga).
  • BMI between 35 and 45 kg/m2.

Exclusion Criteria:

  • Pregnant or lactating
  • Following a prescribed diet for any reason in the past 3 months
  • Celiac disease, Crohn's disease or any condition altering nutritional requirements.
  • Allergies or food intolerances, as well as antibiotics treatment or usual probiotics intake.

Sites / Locations

  • Hospital Universitario Virgen de la Victoria

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Experimental

Experimental

Arm Label

A balanced hypocaloric diet in macronutrients (MedDiet).

A very low carbohydrate diet (KetoDiet).

An intermittent fasting (IF) approach.

Arm Description

Mediterranean diet based on olive oil as main fat and regular consumption of vegetables (2 daily rations), fruits (3 daily rations), legumes (3 weekly rations), fish (3 weekly rations), with low consumption of red meat and meat products (less than twice a week), dairy foods (less than once a week) and no sweets, pastries or sugary drinks. Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 45% carbohydrates, 35% fat, 20% protein distributed in at least 4 meals (breakfast, lunch, afternoon snack and dinner).

Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 5 % carbohydrates, 65% fat and 30% high biological value protein

In this diet subjects alternate norm caloric diet during 24 h (according to Harris-Benedict equation) and a diet including only 25% of caloric requirements the following 24 h (this day diet will include 5 % carbohydrates, 65% fat and 30% high biological value protein).

Outcomes

Primary Outcome Measures

Changes in body weight after each intervention
Weight in kg

Secondary Outcome Measures

Changes in body composition and in the ratio of free-fat / fat mass loss after the three different dietary interventions.
Ratio in %
Changes in the degree of insulin resistance.
Measured by the HOMA-IR ratio
Changes in the systolic blood pressure
Blood pressure measured in millimeters of mercury
Changes in the diastolic blood pressure
Blood pressure measured in millimeters of mercury
Changes in lipid profile (triglycerides)
Measured in mg/dl
Changes in lipid profile (cholesterol)
Measured in mg/dl
Changes in the degree of ketosis
Measured in mmol/l
Changes in gut microbiota
Change from baseline in 16S rRNA amplicons after 1 month
DNA methylation.
Measured by a Methylation Array of the whole genome interrogating 850000 CpGs.
Changes in the punctuation in neurocognitive test - Trailmaking Test (A - B)
Trailmaking Test (A - B) allows evaluating visual search speed, working memory, motor skills, visual-spatial sequencing, sustained attention, divided attention and mental flexibility (time: reduction in seconds)
Changes in the punctuation in neurocognitive test - Stroop
Stroop measures selective attention and inhibitory control. (increasing scores)
Changes in the punctuation in neurocognitive test - WAISspan
Letters and numbers from the WAISspan for working memory, concentration, auditory sequencing and executive attention. (time: reduction in seconds)
Changes in the punctuation in neurocognitive test - UPPS-P
Trailmaking Test (A - B) allows evaluating visual search speed, working memory, motor skills, visual-spatial sequencing, sustained attention, divided attention and mental flexibility (time: reduction in seconds) Stroop: Measures selective attention and inhibitory control. (increasing scores) Letters and numbers from the WAISspan for working memory, concentration, auditory sequencing and executive attention. (time: reduction in seconds) UPPS-P: Impulse BehaviorScale (Cyders et al. 2007; validated in Spanish by Candido et al, 2012). Self- administered scale that evaluates impulsivity. Scale of items using a 4-point likert scale (min 59 /max 136 points).

Full Information

First Posted
May 18, 2022
Last Updated
September 23, 2022
Sponsor
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
search

1. Study Identification

Unique Protocol Identification Number
NCT05420311
Brief Title
Personalized or Precision Medicine in the Dietary Approach to Obesity
Acronym
PI21/01677
Official Title
Personalized or Precision Medicine in the Dietary Approach to Obesity
Study Type
Interventional

2. Study Status

Record Verification Date
April 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 31, 2022 (Anticipated)
Primary Completion Date
July 1, 2024 (Anticipated)
Study Completion Date
December 1, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The main objective of this project is to apply a precision medicine approach to try to explain the intra-individual variability of the response to different weight loss approaches: a balanced hypocaloric diet in macronutrients (MedDiet), a very low carbohydrate diet (KetoDiet) and an intermittent fasting (IF) approach, and try to establish in a personalized manner with the individual variability in genetics, metabolites, intestinal microbiome, and environmental factors the best dietary strategy for weight loss. As secondary objectives the investigators pretend to O1: To analyze whether individual variability in genetics, epigenetics, intestinal microbiome, and environmental factors determine the changes in insulin resistance, blood pressure, lipid levels and NASH markers after three different dietary interventions. O2: To analyze whether individual variability in genetics, epigenetics, intestinal microbiome, and environmental factors determine the changes in the body composition and the different ratio of free-fat/ fat mass loss after three different dietary interventions. O3: To determine the most effective intervention to increase the loss of fat mass, preserve the free-fat mass and trigger a better metabolic profile. O4: To follow-up changes in gut microbiota and DNA methylation after each of the cross-over dietary interventions. O5: To evaluate the transcriptional response of adipose tissue and elucidate its predictive value for the body-composition changes in patients subjected to the different dietary interventions. O6: To evaluate the influence of D-ß-hydroxybutyrate as well as other short-chain acyl-CoA precursor metabolites in human adipocytes lipolysis by in vitro experimentation and elucidate the influence of metabolite-sensitive histone modifications in the shaping of adipose transcriptional program and lipolysis sensitivity. O7: To develop a machine learning algorithm based on genetics, epigenetics, intestinal microbiome, and environmental factors for the prediction of the best dietary approach for weight loss in a personalized manner. To try to respond to these objectives, the investigators will apply two models: a randomized cross-over study testing three different dietary weight-loss interventions: MedDiet, KetoDiet, and IF with wash-out periods before each intervention.
Detailed Description
The main objective of this project is to apply a precision medicine approach to try to explain the intra-individual variability of the response to different weight loss approaches: a balanced hypocaloric diet in macronutrients (MedDiet), a very low carbohydrate diet (KetoDiet) and an intermittent fasting (IF) approach, and try to establish in a personalized manner with the individual variability in genetics, metabolites, intestinal microbiome, and environmental factors the best dietary strategy for weight loss. As secondary objectives the investigators pretend to O1: To analyze whether individual variability in genetics, epigenetics, intestinal microbiome, and environmental factors determine the changes in insulin resistance, blood pressure, lipid levels and NASH markers after three different dietary interventions. O2: To analyze whether individual variability in genetics, epigenetics, intestinal microbiome, and environmental factors determine the changes in the body composition and the different ratio of free-fat/ fat mass loss after three different dietary interventions. O3: To determine the most effective intervention to increase the loss of fat mass, preserve the free-fat mass and trigger a better metabolic profile. O4: To follow-up changes in gut microbiota and DNA methylation after each of the cross-over dietary interventions. O5: To evaluate the transcriptional response of adipose tissue and elucidate its predictive value for the body-composition changes in patients subjected to the different dietary interventions. O6: To evaluate the influence of D-ß-hydroxybutyrate as well as other short-chain acyl-CoA precursor metabolites in human adipocytes lipolysis by in vitro experimentation and elucidate the influence of metabolite-sensitive histone modifications in the shaping of adipose transcriptional program and lipolysis sensitivity. O7: To develop a machine learning algorithm based on genetics, epigenetics, intestinal microbiome, and environmental factors for the prediction of the best dietary approach for weight loss in a personalized manner. To try to respond to these objectives, the investigators will apply two models: a randomized cross-over study testing three different dietary weight-loss interventions: MedDiet, KetoDiet, and IF with wash-out periods before each intervention in patients with obesity; and a second cellular approach with adipose tissue from the patients as well as with commercial cells.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity
Keywords
Precision medicine, nutrigenomics, microbiome, obesity, diet

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
A randomized cross-over study testing three different dietary weight-loss interventions
Masking
None (Open Label)
Allocation
Randomized
Enrollment
450 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
A balanced hypocaloric diet in macronutrients (MedDiet).
Arm Type
Experimental
Arm Description
Mediterranean diet based on olive oil as main fat and regular consumption of vegetables (2 daily rations), fruits (3 daily rations), legumes (3 weekly rations), fish (3 weekly rations), with low consumption of red meat and meat products (less than twice a week), dairy foods (less than once a week) and no sweets, pastries or sugary drinks. Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 45% carbohydrates, 35% fat, 20% protein distributed in at least 4 meals (breakfast, lunch, afternoon snack and dinner).
Arm Title
A very low carbohydrate diet (KetoDiet).
Arm Type
Experimental
Arm Description
Diet will produce a 600 kcal per day caloric deficit, according to the Harris-Benedict equation for each subject. Diet will include 5 % carbohydrates, 65% fat and 30% high biological value protein
Arm Title
An intermittent fasting (IF) approach.
Arm Type
Experimental
Arm Description
In this diet subjects alternate norm caloric diet during 24 h (according to Harris-Benedict equation) and a diet including only 25% of caloric requirements the following 24 h (this day diet will include 5 % carbohydrates, 65% fat and 30% high biological value protein).
Intervention Type
Other
Intervention Name(s)
MedDiet Arm
Intervention Description
A balanced hypocaloric diet in macronutrients (MedDiet)
Intervention Type
Other
Intervention Name(s)
KetoDiet Arm
Intervention Description
A very low carbohydrate diet (KetoDiet).
Intervention Type
Other
Intervention Name(s)
IF Arm
Intervention Description
An intermittent fasting (IF) approach
Primary Outcome Measure Information:
Title
Changes in body weight after each intervention
Description
Weight in kg
Time Frame
From baseline to 1 month
Secondary Outcome Measure Information:
Title
Changes in body composition and in the ratio of free-fat / fat mass loss after the three different dietary interventions.
Description
Ratio in %
Time Frame
From baseline to 1 month
Title
Changes in the degree of insulin resistance.
Description
Measured by the HOMA-IR ratio
Time Frame
From baseline to 1 month
Title
Changes in the systolic blood pressure
Description
Blood pressure measured in millimeters of mercury
Time Frame
From baseline to 1 month
Title
Changes in the diastolic blood pressure
Description
Blood pressure measured in millimeters of mercury
Time Frame
From baseline to 1 month
Title
Changes in lipid profile (triglycerides)
Description
Measured in mg/dl
Time Frame
From baseline to 1 month
Title
Changes in lipid profile (cholesterol)
Description
Measured in mg/dl
Time Frame
From baseline to 1 month
Title
Changes in the degree of ketosis
Description
Measured in mmol/l
Time Frame
From baseline to 1 month
Title
Changes in gut microbiota
Description
Change from baseline in 16S rRNA amplicons after 1 month
Time Frame
From baseline to 1 month
Title
DNA methylation.
Description
Measured by a Methylation Array of the whole genome interrogating 850000 CpGs.
Time Frame
From baseline to 1 month
Title
Changes in the punctuation in neurocognitive test - Trailmaking Test (A - B)
Description
Trailmaking Test (A - B) allows evaluating visual search speed, working memory, motor skills, visual-spatial sequencing, sustained attention, divided attention and mental flexibility (time: reduction in seconds)
Time Frame
From baseline to 1 month
Title
Changes in the punctuation in neurocognitive test - Stroop
Description
Stroop measures selective attention and inhibitory control. (increasing scores)
Time Frame
From baseline to 1 month
Title
Changes in the punctuation in neurocognitive test - WAISspan
Description
Letters and numbers from the WAISspan for working memory, concentration, auditory sequencing and executive attention. (time: reduction in seconds)
Time Frame
From baseline to 1 month
Title
Changes in the punctuation in neurocognitive test - UPPS-P
Description
Trailmaking Test (A - B) allows evaluating visual search speed, working memory, motor skills, visual-spatial sequencing, sustained attention, divided attention and mental flexibility (time: reduction in seconds) Stroop: Measures selective attention and inhibitory control. (increasing scores) Letters and numbers from the WAISspan for working memory, concentration, auditory sequencing and executive attention. (time: reduction in seconds) UPPS-P: Impulse BehaviorScale (Cyders et al. 2007; validated in Spanish by Candido et al, 2012). Self- administered scale that evaluates impulsivity. Scale of items using a 4-point likert scale (min 59 /max 136 points).
Time Frame
From baseline to 1 month

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Participants aged ≥ 18 and <70 years old who were derived to the obesity-management unit of the Endocrinology and Nutrition Unit of the Virgen de la Victoria Hospital (Málaga). BMI between 35 and 45 kg/m2. Exclusion Criteria: Pregnant or lactating Following a prescribed diet for any reason in the past 3 months Celiac disease, Crohn's disease or any condition altering nutritional requirements. Allergies or food intolerances, as well as antibiotics treatment or usual probiotics intake.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Isabel Moreno Indias, PhD.
Phone
951032647
Email
Isabel.moreno@ibima.eu
First Name & Middle Initial & Last Name or Official Title & Degree
Franscisco J. Tinahones, MD, PhD.
Phone
951032647
Email
fjtinahones@uma.es
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Franscisco J. Tinahones, MD, PhD.
Organizational Affiliation
Instituto de Investigacion Biomedica de Malaga
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Universitario Virgen de la Victoria
City
Málaga
ZIP/Postal Code
29010
Country
Spain
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Francisco J Tinahones, MD, PhD
Phone
+34 951 932 734
Email
fjtinahones@uma.es
First Name & Middle Initial & Last Name & Degree
Isabel Moreno-Indias, PhD
Phone
+34 951032647
Email
isabel.moreno@ibima.eu

12. IPD Sharing Statement

Learn more about this trial

Personalized or Precision Medicine in the Dietary Approach to Obesity

We'll reach out to this number within 24 hrs